Filing Details
- Accession Number:
- 0001209191-22-005748
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-31 18:47:33
- Reporting Period:
- 2022-01-31
- Accepted Time:
- 2022-01-31 18:47:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1290149 | Sierra Oncology Inc. | SRRA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1551965 | Gaurav Aggarwal | C/O Sierra Oncology, Inc. 1820 Gateway Drive, Suite 110 San Mateo CA 94404 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-01-31 | 800,000 | $27.00 | 2,735,853 | No | 4 | P | Indirect | By Vivo Opportunity Fund, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Vivo Opportunity Fund, L.P. |
Footnotes
- The Reporting Person is a managing member of Vivo Opportunity, LLC, which is the general partner of Vivo Opportunity Fund, L.P. The Reporting Person may be deemed to share voting and dispositive power over the securities held by Vivo Opportunity Fund, L.P. with four other managing members of Vivo Opportunity, LLC. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.